Abstract
It is unclear what the risk of allergic reactions is with appropriately given dilute i.v. redback spider antivenom (RBSAV). Ninety-five i.v. administrations of RBSAV referred from January 2001 to November 2006 were reviewed. All patients had local pain, 72% radiating pain, 57% diaphoresis and 39% systemic effects. Four patients (4%) had immediate systemic hypersensitivity reactions: none were severe, one was moderate and three mild. In 32 patients followed up for 2 weeks, three (10%) developed serum sickness. RBSAV given i.v. had a low reaction rate. � 2007 Royal Australasian College of Physicians.
Original language | English |
---|---|
Pages (from-to) | 820-822 |
Number of pages | 3 |
Journal | Internal Medicine Journal |
Volume | 37 |
Issue number | 12 |
Publication status | Published - 2007 |